Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency.

Study Objective: To assess the short-term efficacy and safety of an accelerated intravenous iron regimen in hospitalized patients with heart failure and iron deficiency.

Design: Prospective, single-arm, open-label study.

Setting: Large tertiary care medical center.

Advanced therapies for end-stage heart failure.

Management of the advanced heart failure patient can be complex. Therapies include cardiac transplantation and mechanical circulatory support, as well inotropic agents for the short-term. Despite a growing armamentarium of resources, the clinician must carefully weigh the risks and benefits of each therapy to develop an optimal treatment strategy.